1.12

0.00% 0.00

Inovio Pharmaceuticals Inc (INO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.12

Offen:

$1.13

24-Stunden-Volumen:

909.07K

Relative Volume:

0.58

Marktkapitalisierung:

$91.38M

Einnahmen:

$65,300

Nettoeinkommen (Verlust:

$-84.95M

KGV:

-0.5794

EPS:

-1.9332

Netto-Cashflow:

$-88.92M

1W Leistung:

-2.61%

1M Leistung:

-35.63%

6M Leistung:

-52.34%

1J Leistung:

-40.74%

1-Tages-Spanne:

$1.11

$1.13

1-Wochen-Bereich:

$1.11

$1.23

52-Wochen-Spanne:

$1.03

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Firmenname

Inovio Pharmaceuticals Inc

Sektor

Healthcare (1107)

Branche

Biotechnology (615)

Telefon

(858) 410-3134

Adresse

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Mitarbeiter

112

Twitter

@inoviopharma

Nächster Verdiensttermin

2026-05-12

Neueste SEC-Einreichungen

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INO Inovio Pharmaceuticals Inc	1.12	93.83M	65,300	-84.95M	-88.92M	-1.9332
VRTX Vertex Pharmaceuticals Inc	424.83	109.41B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	703.44	76.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	786.32	48.20B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.44	40.31B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	293.58	33.13B	5.36B	287.73M	924.18M	2.5229

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-09	Eingeleitet	Piper Sandler	Overweight
2024-05-14	Eingeleitet	Stephens	Overweight
2024-01-25	Hochstufung	Oppenheimer	Perform → Outperform
2022-11-09	Herabstufung	Maxim Group	Buy → Hold
2022-11-01	Herabstufung	BofA Securities	Neutral → Underperform
2022-07-19	Fortgesetzt	RBC Capital Mkts	Sector Perform
2022-05-11	Herabstufung	Oppenheimer	Outperform → Perform
2022-01-21	Hochstufung	BofA Securities	Underperform → Neutral
2021-12-29	Fortgesetzt	Jefferies	Hold
2021-09-10	Herabstufung	BofA Securities	Neutral → Underperform
2021-06-24	Eingeleitet	Jefferies	Hold
2021-03-23	Eingeleitet	BofA Securities	Neutral
2021-02-12	Eingeleitet	Oppenheimer	Outperform
2020-11-17	Herabstufung	ROTH Capital	Neutral → Sell
2020-11-10	Hochstufung	ROTH Capital	Sell → Neutral
2020-09-28	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Hochstufung	Maxim Group	Hold → Buy
2020-07-01	Herabstufung	Maxim Group	Buy → Hold
2020-07-01	Herabstufung	ROTH Capital	Neutral → Sell
2020-06-29	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-06-26	Herabstufung	Stifel	Buy → Hold
2020-05-21	Eingeleitet	The Benchmark Company	Buy
2020-04-30	Herabstufung	ROTH Capital	Buy → Neutral
2020-03-13	Herabstufung	Piper Sandler	Overweight → Neutral
2020-03-13	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Eingeleitet	ROTH Capital	Buy
2018-02-15	Bestätigt	Maxim Group	Buy
2017-10-18	Eingeleitet	RBC Capital Mkts	Outperform
2017-09-06	Eingeleitet	Citigroup	Buy
2017-06-08	Hochstufung	Piper Jaffray	Neutral → Overweight
2017-05-24	Bestätigt	Maxim Group	Buy
2017-03-16	Hochstufung	Maxim Group	Hold → Buy
2017-03-16	Herabstufung	Piper Jaffray	Overweight → Neutral

Alle ansehen

Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten

Apr 29, 2026

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 29, 2026

INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill

Apr 29, 2026

Apr 28, 2026

Inovio Pharmaceuticals (INO) price target decreased by 12.21% to 6.90 - MSN

Apr 28, 2026

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 28, 2026

Apr 27, 2026

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 27, 2026